Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
4.050
+0.250 (6.58%)
At close: Aug 5, 2026, 4:00 PM EDT
4.100
+0.050 (1.23%)
After-hours: Aug 5, 2026, 6:30 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $8.68 million as of August 5, 2026. Its market cap has increased by 163.08% in one year.
Market Cap
8.68M
Enterprise Value
3.56M
1-Year Change
163.08%
Ranking
Category
Stock Price
$4.05
ChartMarket Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.30M to $8.68M, a decrease of -66.99%. That is a compound annual growth rate of -12.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 8.68M | 63.81% |
| Dec 31, 2025 | 5.30M | -18.46% |
| Dec 31, 2024 | 6.50M | 182.61% |
| Dec 29, 2023 | 2.30M | -60.34% |
| Dec 30, 2022 | 5.80M | -89.66% |
| Dec 31, 2021 | 56.10M | 131.82% |
| Dec 31, 2020 | 24.20M | -2.81% |
| Dec 31, 2019 | 24.90M | -25.89% |
| Dec 31, 2018 | 33.60M | 27.76% |
| Jul 30, 2018 | 26.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 8.94M |
| CNS Pharmaceuticals | 8.46M |
| Immuron | 8.25M |
| Lexaria Bioscience | 7.85M |
| Niki BioSolutions | 7.79M |
| AEON Biopharma | 7.76M |
| Bolt Biotherapeutics | 7.65M |
| MetaVia | 7.64M |